Boehringer Sex Pill May Not Aid Women, FDA Staff Say (Update1) - Bloomberg.com
The drug flibanserin “failed to demonstrate a statistically significant improvement” in sexual desire, Food and Drug Administration staff said in a review released today. It was also linked to appendicitis, depression and loss of consciousness. Side effects led about 15 percent of women to stop treatment with the drug, the review said.
No comments:
Post a Comment